JP2016501858A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016501858A5 JP2016501858A5 JP2015543432A JP2015543432A JP2016501858A5 JP 2016501858 A5 JP2016501858 A5 JP 2016501858A5 JP 2015543432 A JP2015543432 A JP 2015543432A JP 2015543432 A JP2015543432 A JP 2015543432A JP 2016501858 A5 JP2016501858 A5 JP 2016501858A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- amino acids
- cancer
- side chain
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1220889.8 | 2012-11-21 | ||
| GBGB1220889.8A GB201220889D0 (en) | 2012-11-21 | 2012-11-21 | CD44v6-derived peptides for treating metastasizing cancers |
| PCT/EP2013/074404 WO2014079943A1 (en) | 2012-11-21 | 2013-11-21 | Cd44v6-derived peptides for treating metastasizing cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016501858A JP2016501858A (ja) | 2016-01-21 |
| JP2016501858A5 true JP2016501858A5 (enExample) | 2016-12-22 |
Family
ID=47521460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015543432A Pending JP2016501858A (ja) | 2012-11-21 | 2013-11-21 | 転移性癌を処置するためのｃｄ４４ｖ６由来ペプチド |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9593146B2 (enExample) |
| EP (1) | EP2922563B1 (enExample) |
| JP (1) | JP2016501858A (enExample) |
| AU (1) | AU2013349703B2 (enExample) |
| CA (1) | CA2892147A1 (enExample) |
| DK (1) | DK2922563T3 (enExample) |
| ES (1) | ES2765037T3 (enExample) |
| GB (1) | GB201220889D0 (enExample) |
| HU (1) | HUE047126T2 (enExample) |
| IL (1) | IL238606B (enExample) |
| LT (1) | LT2922563T (enExample) |
| SI (1) | SI2922563T1 (enExample) |
| WO (1) | WO2014079943A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201421647D0 (en) | 2014-12-05 | 2015-01-21 | Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie | CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases |
| EP3466963A1 (en) * | 2017-10-05 | 2019-04-10 | Suigeneris Farmacosmetics, S.L. | Anticancer peptides and uses thereof |
| KR102194025B1 (ko) | 2017-12-15 | 2020-12-22 | 경북대학교 산학협력단 | CD44v6에 결합하는 펩타이드 및 이의 용도 |
| JP7510874B2 (ja) | 2017-12-22 | 2024-07-04 | ヒプラ シエンティフィック エセ．エレ．ウ． | マイコプラズマ及びブタサーコウイルスに対する皮内混合ワクチン |
| EP4464714A1 (en) | 2023-05-19 | 2024-11-20 | Karlsruher Institut für Technologie | Screening method for cell-repelling peptides |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5696229A (en) | 1995-03-16 | 1997-12-09 | The University Of Virginia Patent Foundation | Polypeptide with laminin cell adhesion and morphogenesis activity |
| DE19540515C1 (de) * | 1995-10-31 | 1997-02-06 | Boehringer Ingelheim Int | Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten |
| EP1258255A1 (en) * | 2001-05-18 | 2002-11-20 | Boehringer Ingelheim International GmbH | Conjugates of an antibody to CD44 and a maytansinoid |
| JP2003089700A (ja) | 2001-09-18 | 2003-03-28 | Life Science Management:Kk | ペプチド |
| EP1417974A1 (en) * | 2002-11-08 | 2004-05-12 | Boehringer Ingelheim International GmbH | Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy |
| WO2005065709A2 (de) | 2003-12-24 | 2005-07-21 | Boehringer Ingelheim International Gmbh | Gefriergetrocknete formulierung von antikörperkonjugaten |
| DE602004027255D1 (de) * | 2004-10-14 | 2010-07-01 | Karlsruher Inst Technologie | Peptidische Verbindungen und deren Ableitungen für die Behandllung von menschlichen Krankheiten durch Hemmung der Signalübertragung über Wachstumfaktoren |
| EP2218457B1 (en) * | 2009-02-16 | 2011-09-07 | Karlsruher Institut für Technologie | CD44v6 peptides as inhibitors of bacterial infections |
| EP2266593A1 (en) * | 2009-06-24 | 2010-12-29 | Karlsruher Institut für Technologie | Use of CD44v6 in the treatment of ophthalmic diseases |
| WO2011022335A1 (en) | 2009-08-21 | 2011-02-24 | Mount Sinai School Of Medicine Of New York University | Methods of using cd44 fusion proteins to treat cancer |
-
2012
- 2012-11-21 GB GBGB1220889.8A patent/GB201220889D0/en not_active Ceased
-
2013
- 2013-11-21 WO PCT/EP2013/074404 patent/WO2014079943A1/en not_active Ceased
- 2013-11-21 CA CA2892147A patent/CA2892147A1/en not_active Abandoned
- 2013-11-21 SI SI201331649T patent/SI2922563T1/sl unknown
- 2013-11-21 LT LTEP13798617.0T patent/LT2922563T/lt unknown
- 2013-11-21 EP EP13798617.0A patent/EP2922563B1/en not_active Not-in-force
- 2013-11-21 ES ES13798617T patent/ES2765037T3/es active Active
- 2013-11-21 DK DK13798617.0T patent/DK2922563T3/da active
- 2013-11-21 US US14/407,283 patent/US9593146B2/en not_active Expired - Fee Related
- 2013-11-21 JP JP2015543432A patent/JP2016501858A/ja active Pending
- 2013-11-21 AU AU2013349703A patent/AU2013349703B2/en not_active Ceased
- 2013-11-21 HU HUE13798617A patent/HUE047126T2/hu unknown
-
2015
- 2015-05-04 IL IL238606A patent/IL238606B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016501858A5 (enExample) | ||
| ZA202006432B (en) | T cell receptors | |
| NZ731571A (en) | T cell receptors | |
| MX2022001134A (es) | Proteinas quimericas de factor viii y usos de estas. | |
| BR112014000466A2 (pt) | polipeptídeos quiméricos e híbridos fator viii, métodos de uso dos mesmos | |
| WO2013151672A3 (en) | Modified polynucleotides for the production of oncology-related proteins and peptides | |
| TN2017000085A1 (en) | Polypeptide having a polyester degrading activity and uses thereof | |
| MX389173B (es) | Receptores de celulas t. | |
| AU2017248120A1 (en) | T cell receptors | |
| PE20180505A1 (es) | Peptidos y combinacion de peptidos y andamiajes novedosos para su uso en inmunoterapia contra carcinoma de celulas renales (rcc) y otros canceres | |
| CL2013003634A1 (es) | Complejo que comprende una proteina de fusion que comprende, un peptido viral, peptido conector, microglobulina beta 2 , peptido conector, dominios extracelulares alfa 1, 2 y 3 de mhc de clase i y un tercer peptido conector; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso | |
| NZ587105A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| JP2012126742A5 (enExample) | ||
| WO2011123830A3 (en) | Alpha 1-antitrypsin compositions and methods of making and using same | |
| IN2014DN09963A (enExample) | ||
| MX2016011517A (es) | Peptidos de crmp2 no narcoticos que seleccionan como diana canales de sodio para el dolor cronico. | |
| UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
| HRP20150664T1 (hr) | Antikancerogeni fuzijski protein | |
| SI2718434T1 (en) | Compounds and procedures for the treatment of celiac disease | |
| JP2014529399A5 (enExample) | ||
| JP2010265269A5 (enExample) | ||
| JP2016501857A5 (enExample) | ||
| MY171183A (en) | Polypeptide glycosylated with sialylated sugar chain | |
| ES2526109R2 (es) | Péptido y composición farmacéutica para el tratamiento del cáncer | |
| MX2015016560A (es) | Proteina analgesica aislada de la secrecion de la rana trachycephalous venulosus. |